April 08, 2014
Purdue Pharma LP fired off a complaint in New York federal court last week alleging Teva Pharmaceuticals USA Inc. will infringe its patent by marketing a generic version of the popular painkiller OxyContin, just months after a judge found that Teva hadn't infringed several other patents covering the drug.